Dual Integrin Antagonist

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Asthma

Phase 2

Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma

CompletedNCT00048022

Hoffmann-La RocheAsthma

Start: 2002-10-25End: 2004-02-02Updated: 2017-06-19

Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

CompletedNCT00048009

Hoffmann-La RocheAsthma

Start: 2002-10-25End: 2004-02-02Updated: 2017-06-19